|
| |
Cellexus Biosystems
announces the world-wide launch of the CellMaker Lite disposable
bioreactor, with backing from the British Department of Trade and
Industry.
22nd August 2006 Cellexus
Biosystems PLC of Cambridgeshire, UK (stock symbol: CBIO) announces the
world-wide launch of the CellMaker Lite disposable bioreactor. The Company will
be exhibiting its products across the globe at a series of high profile
conferences, as it introduces the system to scientists throughout the world.
The Company’s first international showing is in Australia, at ComBio 2006 in
Brisbane (24th – 28th September), followed immediately by its first viewing in
Dublin, Ireland (24-25th October) at Europe’s BioProduction conference. Shortly
after, the Company is exhibiting in the USA for the first time at IBC’s fully
sold out BioProcess International conference in San Francisco, on the 6-9th
November. Other conferences will be attended, including London’s PABORD
conference on the 13th -14th September 2006.
“This series of events mark the international debut of the CellMaker Lite
disposable bioreactor system” explained Dr Kevin Auton, CEO of Cellexus
Biosystems. “Our system is novel and offers a number of benefits to researchers
over existing disposable bioreactors and we are keen to take it to our customers
and show them the CellMaker Lite first hand. The best way to do this is for us
to undertake a global road show so that customers can see this for themselves
and these conferences are an ideal way to achieve this.”
The international launch has also attracted the involvement and support of the
UK’s Department of Trade and Industry (UKTI) through its Passport to Export
programme. Cellexus Biosystems successfully applied for funding to assist it
with these export activities and is enjoying the help of British Embassies and
Consulates around the world through the Overseas Market Introduction Service (OMIS).
“The support provided by the UKTI to help us promote the CellMaker Lite into
international markets through the Passport to Export Programme has been
excellent. In addition to financial support, the provision of advice, reviews of
our readiness for export and local assistance in Cambridgeshire has made the
process more effective and easier to achieve.” commented Dr Auton.
Dr Belinda Clarke, the UKTI’s export Biotechnology sector specialist for the
Cambridgeshire region, commented “Our role is to assist companies such as
Cellexus Biosystems achieve their full potential in international markets. It is
often difficult for smaller companies to achieve a presence on the World’s stage
and we are delighted at the success being achieved by Cellexus Biosystems. From
the outset, the Company’s management embraced the UKTI’s Passport to Export
programme, participated in the training workshops we provided and have worked
closely with us. We are very pleased for Cellexus and we will continue to
support their efforts through the on-going Passport to Export scheme and wish
them ever increasing success as one of the regions exporters as their
international business flourishes.”
The CellMaker Lite will be demonstrated at the following renowned conferences:
13-14th September PABOARD pharmaceutical out sourcing, London
24-28th September ComBio 2006, Brisbane, Australia
24-25th October Bio Production, Dublin, Ireland
6-9th November BioProcess International, San Francisco, USA
The Directors of Cellexus Biosystems PLC take responsibility for this press
release.
Ends
Notes and contact details to follow …
About Cellexus Biosystems PLC
Cellexus Biosystems has developed a range of value-added disposables to help
researchers in the biopharmaceutical industry and academia develop new
biopharmaceutical products from cell lines. Biopharmaceuticals are the new breed
of medicines, generated by culturing cells in bioreactors. These medicines are
often proteins, such as antibodies, vaccines and the potential offered by stem
cell research. Sales of biopharmaceuticals reached US$60 billion in 2005 and are
growing at 20% per annum.
In an unusual step for an early stage company, Cellexus Biosystems was admitted
onto the Plus Markets Exchange (www.ofex.com) on the 3rd of May 2006 (stock
symbol: CBIO), just six months after being incorporated as a public limited
company (PLC). A listing on the exchange means that Cellexus Biosystems can now
also raise funds from those private investors who manage their own Self Invested
Personal Pension Scheme (SIPPS) as a result of the changes in the regulations,
in addition to accepting investment from High Net Worth Individuals (business
angels). This gives the Company access to sources of capital that are not
available to other early stage companies, who must compete for investment from a
small number of
The Company has already developed a family of products. Three products will be
developed all based around the core technology - the CellexusBagTM – and will be
marketed under the name: CellMaker LiteTM. These products potentially offer
significant technological improvements for cell culture and cell growth in the
developing disposables market.
Unlike competitive products, the CellexusBag products do not need to be stirred,
shaken, rocked or rolled, which means the equipment used to manage the cell
culture process is very simple and inexpensive. A patent application protecting
the Company’s intellectual property was filed in December 2005.
Cellexus Biosystems PLC:
Dr Kevin Auton, CEO
New Tel: +44 1354 657 407
New Fax: +44 870 135 5536
New address: Cellexus Biosystems PLC
Hereward Innovation Centre, Hostmoor Avenue, March,
Cambridgeshire, PE15 0AX,
United Kingdom
Email: kevin.auton@cellexusbiosystems.com
www.cellexusbiosystems.com
CORPORATE ADVISER:
JM Finn & Co
Salisbury House, London Wall, London EC2M 5TA
Mr Clive Carver
Tel: +44 207 628 9688
Email: clive.carver@jmfinn.com
www.jmfinn.com
MEDIA CONTACT FOR CELLEXUS BIOSYSTEMS PLC
Not This Limited
Tel: +44 1480 352 821
Email: info@notthislimited.co.uk
www.notthislimited.co.uk
| |
|
